We are monitoring the impact of COVID-19 on Latin America Regenerative Medicines Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 244
Share on
Share on

Latin America Regenerative Medicines Market Research Report – Segmented By Product, By Therapy, By Application & By Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) – Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: August, 2019
ID: 244
Pages: 145

The Latin American Regenerative Medicines Market is expected to reach USD 5.21 billion by 2024 from USD 1.72 billion in 2019, growing at a CAGR of 24.80% during the forecast period.

Regenerative medicine is a very sensitive treatment and requires expertise persons to handle. Small contamination can lead to mutation or can damage the entire cell culture.

COVID-19 impact

The abrupt change caused by COVID-19 Pandemic researcher has difficulty in conducting their regenerative medicine treatment. Transportation is also one of the obstacles hindering the growth of the market in this region. Increasing COVID-19 cases and demand to find a vaccine with various techniques is surging the growth of this market.

Government policies and private funding are supporting researchers. Companies are highly investing in research and development for making advancement in their regenerative medicine products accelerate market growth in Mexico. In Brazil, an increasing number of regulatory approvals has made the market to grow up significantly. Initiatives taken by the government and adoption of the latest technology are greatly influencing the demand of the market.

In Mexico, increasing incidences of chronic diseases such as Alzheimer’s disease, Parkinson’s disease, diabetes, heart disease, renal failure, osteoporosis, and spinal cord injuries which can be treated with regenerative medicine is a major factor for the market to grow. However, this is an expensive treatment where common people cannot afford is impeding market growth.

In Brazil, growth in this market is largely driven by the introduction of Cures Act for regenerative medicine by the FDA. Increased funding for regenerative medicine research, development of CAR-T cell therapies and increasing demand for regenerative medicine for the treatment of cancer, orthopaedic disorders, and chronic diseases are solely propelling the growth of the market.

This research report segmented and sub-segmented into the following categories:

  • By Product: Cell-Based Products, Acellular Products
  • By Therapy: Cell Therapy, Gene Therapy, Tissue Engineering, and Immunotherapy
  • By Application: Orthopedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System, Oncology, Diabetes, and Other Application
  • By Country: Mexico, Brazil, Argentina, Chile and Rest of Latin America

Prominent companies dominating in the Latin America Regenerative Medicines Market are Vertex Pharmaceuticals Incorporated, Acelity L.P. Inc., Celgene Corporation, StemCells, Inc., Organogenesis Inc., NuVasive, Inc., Vericel Corporation (Genzyme), Japan Tissue Engineering Co., Ltd., Cytori Therapeutics Inc., Advantagene, Inc. and Mesoblast Ltd.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Introduction                                               

                5.2 Product                                        

                                5.2.1 Introduction                           

                                5.2.2 Cell-Based Products                            

                                                5.2.2.1 Autologous Cell-Based Products

                                                5.2.2.2 Allogeneic Cell-Based Products  

                                5.2.3 Acellular Products                

                5.3 Therapy                                       

                                5.3.1 Introduction                           

                                5.3.2 Cell Therapy                           

                                5.3.3 Gene Therapy                       

                                5.3.4 Tissue Engineering                               

                                5.3.5 Immunotherapy                   

                5.4 Application                                 

                                5.4.1 Introduction                           

                                5.4.2 Orthopedic & Musculoskeletal Spine                           

                                5.4.3 Dermatology                          

                                5.4.4 Cardiovascular                       

                                5.4.5 Central Nervous System                   

                                5.4.6 Oncology                 

                                5.4.7 Diabetes                  

                                5.4.8 Other Applications                               

6. Geographical Analysis                                                              

                                6.4.1 Introduction                           

                                6.4.2 Brazil                          

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Vertex Pharmaceuticals Incorporated (U.S.)                                

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Acelity L.P. Inc. (U.S.)                                             

                8.3 Celgene Corporation (U.S.)                                 

                8.4 StemCells, Inc. (U.S.)                                              

                8.5 Organogenesis Inc.  (U.S.)                                    

                8.6 NuVasive, Inc. (U.S.)                                              

                8.7 Vericel Corporation (Genzyme) (U.S.)                                            

                8.8 Cytori Therapeutics Inc. (U.S.)                                            

                8.9 Advantagene, Inc. (U.S.)                                      

                8.10 Mesoblast Ltd. (Australia)                                  

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  2. Latin America Regenerative Medicines Market By Product, From 2019-2024(USD Billion)
  3. Latin America Cell-Based Products Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  4. Latin America Acellular Products Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  5. Latin America Regenerative Medicines Market By Therapy, From 2019-2024(USD Billion)
  6. Latin America Cell Therapy Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  7. Latin America Gene Therapy Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  8. Latin America Tissue Engineering Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  9. Latin America Immunotherapy Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  10. Latin America Regenerative Medicines Market By Application, From 2019-2024(USD Billion)
  11. Latin America Orthopedic & Musculoskeletal Spine Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  12. Latin America Dermatology Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  13. Latin America Cardiovascular Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  14. Latin America Central Nervous System Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  15. Latin America Oncology Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  16. Latin America Diabetes Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  17. Latin America Other Applications of Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  18. Brazil Regenerative Medicines Market By Product, From 2019-2024(USD Billion)
  19. Brazil Regenerative Medicines Market By Therapy, From 2019-2024(USD Billion)
  20. Brazil Regenerative Medicines Market By Application, From 2019-2024(USD Billion)
  21. Argentina Regenerative Medicines Market By Product, From 2019-2024(USD Billion)
  22. Argentina Regenerative Medicines Market By Therapy, From 2019-2024(USD Billion)
  23. Argentina Regenerative Medicines Market By Application, From 2019-2024(USD Billion)
  24. Mexico Regenerative Medicines Market By Product, From 2019-2024(USD Billion)
  25. Mexico Regenerative Medicines Market By Therapy, From 2019-2024(USD Billion)
  26. Mexico Regenerative Medicines Market By Application, From 2019-2024(USD Billion)
  27. Latin America Cell-Based Products Regenerative Medicines Market By Type, From 2019-2024(USD Billion)
  28. Latin America Autologous Cell-Based Products Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  29. Latin America Allogeneic Cell-Based Products Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  30. Brazil Cell-Based Products Regenerative Medicines Market By Type, From 2019-2024(USD Billion)
  31. Argentina Cell-Based Products Regenerative Medicines Market By Type, From 2019-2024(USD Billion)
  32. Mexico Cell-Based Products Regenerative Medicines Market By Type, From 2019-2024(USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample